HTA81 Comparing Clinical Benefit Criteria in Health Technology Assessment of Oncology Drugs in the Netherlands and Europe: Driving Real Value or Inequal Access?
Abstract
Authors
Marnix Uyterlinde Laura van der Linde David Maarten Smalbrugge Ha Anh Pham